FILTER

FILTERED ARTICLE RESULTS

Funding Environment: Life Sciences Enter the Mainstream

April 20, 2021
The past 12 months been transformative for the life science industry in USA, and GBR explores how the funding environment has evolved to provide the influx of capital to sustain its innovations.

Turkey Pharmaceuticals: Bringing All Actors Together

June 17, 2020
Industry, university, investors - the two-way bridge to the knowledge gap.

Turkey’s Nascent Biopharma Sector: The Transition to Large Molecules

May 15, 2020
The Turkish pharma industry is on the eve of a rebirth as it seeks to grow a biopharma component.

Impact of COVID-19 in Turkey

May 14, 2020
Efforts to stave off the crisis are consequential in shaping future health and welfare policy.

India’s API Industry: Exporting to the World

March 17, 2020
From being a net importer of APIs, India is now a world-leading exporter.

Made in Turkey: The localization policy and its effects

February 12, 2020
Localisation efforts are shaping the dynamics between local and foreign companies.

The World’s Pharmacy: India’s Generic Drug Industry

February 12, 2020
India must adapt to maintain its position as the world’s largest supplier of generic drugs.

MACIG

SUBSCRIBE TO OUR NEWSLETTER

RECENTLY PUBLISHED

Italy Lifesciences 2021

PARTNER EVENTS